Cost-effectiveness of Fluid Resuscitation of Critically Ill Adults: New Insights From Uncharted Territory

Affiliations

¹ Department of Pulmonary Allergy and Critical Care Medicine, University of Massachusetts Medical School, Worcester, MA. Electronic address: craig.lilly@umassmed.edu.
² Department of Pulmonary Allergy and Critical Care Medicine, University of Massachusetts Medical School, Worcester, MA.

Editorial

Craig M Lilly et al. Chest. 2016 Dec.

. 2016 Dec;150(6):1179-1180.

doi: 10.1016/j.chest.2016.10.011.

¹ Department of Pulmonary Allergy and Critical Care Medicine, University of Massachusetts Medical School, Worcester, MA. Electronic address: craig.lilly@umassmed.edu.
² Department of Pulmonary Allergy and Critical Care Medicine, University of Massachusetts Medical School, Worcester, MA.

No abstract available

Comment on

Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long-term outcomes and cost-effectiveness analysis of a cohort from CHEST.
Taylor C, Thompson K, Finfer S, Higgins A, Jan S, Li Q, Liu B, Myburgh J; Crystalloid versus Hydroxyethyl Starch Trial (CHEST) investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Taylor C, et al. Lancet Respir Med. 2016 Oct;4(10):818-825. doi: 10.1016/S2213-2600(16)30120-5. Epub 2016 Jun 17. Lancet Respir Med. 2016. PMID: 27324967 Clinical Trial.